1
TITLE: A randomized phase II trial of everolimus and letrozole or hormonal therapy in women with advanced, persistent or recurrent endometrial carcinoma: A GOG Foundation study  Full Text
AUTHORS: Brian M Slomovitz; Virginia L Filiaci; Joan L Walker; Michael C Taub; Karen A Finkelstein; John W Moroney; Aimee C Fleury; Carolyn Y Muller; Laura L Holman; Larry J Copeland; David Scott Miller ; Robert L Coleman;
PUBLISHED: 2022, SOURCE: Gynecologic Oncology, VOLUME: 164, ISSUE: 3
INDEXED IN: Scopus CrossRef: 19
2
TITLE: Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial
AUTHORS: Matthew A Powell; Virginia L Filiaci; Martee L Hensley; Helen Q Huang; Kathleen N Moore; Krishnansu S Tewari; Larry J Copeland; Angeles A Secord; David G Mutch; Alessandro Santin; David P Warshal; Nick M Spirtos; Paul A DiSilvestro; Olga B Ioffe; David Scott Miller ;
PUBLISHED: 2022, SOURCE: Journal of Clinical Oncology, VOLUME: 40, ISSUE: 9
INDEXED IN: Scopus CrossRef: 35
3
TITLE: Patient reported outcomes for cisplatin and radiation followed by carboplatin/paclitaxel versus carboplatin/paclitaxel for locally advanced endometrial carcinoma: An NRG oncology study  Full Text
AUTHORS: Ursula A Matulonis; Helen Q Huang; Virginia L Filiaci; Marcus Randall; Paul A DiSilvestro; Katherine M Moxley; Jeffrey M Fowler; Matthew A Powell; Nick M Spirtos; Krishnansu S Tewari; William E Richards; John M Nakayama; David G Mutch; David Scott Miller ; Daniela Matei; Lari B Wenzel;
PUBLISHED: 2021, SOURCE: Gynecologic Oncology
INDEXED IN: Scopus CrossRef: 5
4
TITLE: Progress in endometrial cancer: Contributions of the former Gynecologic Oncology Group  Full Text
AUTHORS: David Scott Miller ; Marcus E Randall; Virginia Filiaci;
PUBLISHED: 2020, SOURCE: Gynecologic Oncology, VOLUME: 157, ISSUE: 2
INDEXED IN: Scopus CrossRef: 4
5
TITLE: An international randomized phase III trial of pulse actinomycin-D versus multi-day methotrexate for the treatment of low risk gestational trophoblastic neoplasia; NRG/GOG 275  Full Text
AUTHORS: Julian C Schink; Virginia Filiaci; Helen Q Huang; John Tidy; Matthew Winter; Jeanne Carter; Nancy Anderson; Katherine Moxley; Akira Yabuno; Sarah E Taylor; Christina Kushnir; Neil Horowitz; David Scott Miller ;
PUBLISHED: 2020, SOURCE: Gynecologic Oncology, VOLUME: 158, ISSUE: 2
INDEXED IN: Scopus CrossRef: 17
6
TITLE: Carboplatin and paclitaxel for advanced endometrial cancer: Final overall survival and adverse event analysis of a phase III trial (NRG Oncology/GOG0209)
AUTHORS: David Scott Miller ; Virginia L Filiaci; Robert S Mannel; David E Cohn; Takashi Matsumoto; Krishnansu S Tewari; Paul DiSilvestro; Michael L Pearl; Peter A Argenta; Matthew A Powell; Susan L Zweizig; David P Warshal; Parviz Hanjani; Michael E Carney; Helen Huang; David Cella; Richard Zaino; Gini F Fleming;
PUBLISHED: 2020, SOURCE: Journal of Clinical Oncology, VOLUME: 38, ISSUE: 33
INDEXED IN: Scopus CrossRef: 150
7
TITLE: Phase III trial: Adjuvant pelvic radiation therapy versus vaginal brachytherapy plus paclitaxel/ carboplatin in high-intermediate and high-risk early stage endometrial cancer
AUTHORS: Marcus E Randall; Virginia Filiaci; Scott S McMeekin; Vivian Von Gruenigen; Helen Huang; Catheryn M Yashar; Robert S Mannel; Jae Weon Kim; Ritu Salani; Paul A DiSilvestro; James J Burke; Thomas Rutherford; Nick M Spirtos; Keith Terada; Penny R Anderson; Wendy R Brewster; William Small; Carol A Aghajanian; David Scott Miller ;
PUBLISHED: 2019, SOURCE: Journal of Clinical Oncology, VOLUME: 37, ISSUE: 21
INDEXED IN: Scopus CrossRef: 213
8
TITLE: Adjuvant chemotherapy plus radiation for locally advanced endometrial cancer
AUTHORS: Daniela Matei; Virginia Filiaci; Marcus E Randall; David Mutch; Margaret M Steinhoff; Paul A DiSilvestro; Katherine M Moxley; Yong M Kim; Matthew A Powell; David M O’Malley; Nick M Spirtos; William Small; Krishnansu S Tewari; William E Richards; John Nakayama; Ursula A Matulonis; Helen Q Huang; David Scott Miller ;
PUBLISHED: 2019, SOURCE: New England Journal of Medicine, VOLUME: 380, ISSUE: 24
INDEXED IN: Scopus CrossRef: 297
9
TITLE: Analysis of patient-reported outcomes (PROs) for GOG-258, a randomized phase III trial of cisplatin and tumor volume directed irradiation followed by carboplatin and paclitaxel (Cis-RT+CP) vs. carboplatin and paclitaxel (CP) for optimally debulked, locally advanced endometrial carcinoma: A Gynecologic Oncology Group/NRG study.
AUTHORS: Ursula A Matulonis; Virginia L Filiaci; Helen Q Huang; Marcus Randall; Byoung Kim; Paul DiSilvestro; Katherine M Moxley; David M O'Malley; Matthew A Powell; Nicola M Spirtos; Krishnansu Sujata Tewari; William Richards; John Nakayama; Margaret Steinhoff; David Gardner Mutch; David Scott Miller ; Lari B Wenzel; Daniela Matei;
PUBLISHED: 2018, SOURCE: Journal of Clinical Oncology, VOLUME: 36, ISSUE: 15_suppl
INDEXED IN: CrossRef: 4
10
TITLE: Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol  Full Text
AUTHORS: William T Creasman; Shamshad Ali; David G Mutch; Richard J Zaino; Matthew A Powell; Robert S Mannel; Floor J Backes; Paul A DiSilvestro; Peter A Argenta; Michael L Pearl; Shashikant B Lele; Saketh R Guntupalli; Steven Waggoner; Nick Spirtos; John F Boggess; Robert P Edwards; Virginia L Filiaci; David Scott Miller ;
PUBLISHED: 2017, SOURCE: Gynecologic Oncology, VOLUME: 145, ISSUE: 3
INDEXED IN: Scopus CrossRef: 51
Page 1 of 2. Total results: 12.